2325 related articles for article (PubMed ID: 20377662)
21. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
22. Identifying factors that affect patients' willingness to pay for inhaled insulin.
Pinto SL; Holiday-Goodman M; Black CD; Lesch D
Res Social Adm Pharm; 2009 Sep; 5(3):253-61. PubMed ID: 19733826
[TBL] [Abstract][Full Text] [Related]
23. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy.
Scherbaum WA
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137
[TBL] [Abstract][Full Text] [Related]
24. Alternatives to animal experimentation in basic research.
Gruber FP; Hartung T
ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
[TBL] [Abstract][Full Text] [Related]
25. Six Sigma: not for the faint of heart.
Benedetto AR
Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
[TBL] [Abstract][Full Text] [Related]
26. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
27. Unlocking the opportunity of tight glycaemic control. Innovative delivery of insulin via the lung.
Patton JS
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S5-8. PubMed ID: 16135136
[TBL] [Abstract][Full Text] [Related]
28. Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practice.
Heine RJ
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S19-23. PubMed ID: 16135135
[TBL] [Abstract][Full Text] [Related]
29. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
30. The Cure for Cancer: Not If but When.
Black KL
Oncologist; 1997; 2(5):IX-X. PubMed ID: 10388068
[TBL] [Abstract][Full Text] [Related]
31. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
32. Inhaled insulin.
Arnolds S; Heise T
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):555-71. PubMed ID: 18054735
[TBL] [Abstract][Full Text] [Related]
33. Alternative strategies in drug development: clinical pharmacological aspects.
Kuhlmann J
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
[TBL] [Abstract][Full Text] [Related]
34. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
35. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
[TBL] [Abstract][Full Text] [Related]
36. Can inhaled insulin be used for the treatment of diabetes mellitus?
de Galan BE
Expert Rev Pharmacoecon Outcomes Res; 2008 Feb; 8(1):33-42. PubMed ID: 20528354
[TBL] [Abstract][Full Text] [Related]
37. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
38. Review of clinical trials: update on oral insulin spray formulation.
Pozzilli P; Raskin P; Parkin CG
Diabetes Obes Metab; 2010 Feb; 12(2):91-6. PubMed ID: 19889002
[TBL] [Abstract][Full Text] [Related]
39. Alternative routes of insulin delivery.
Krishnankutty RK; Mathew A; Sedimbi SK; Suryanarayan S; Sanjeevi CB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 34(10):933-48. PubMed ID: 19893243
[TBL] [Abstract][Full Text] [Related]
40. Oral insulin and buccal insulin: a critical reappraisal.
Heinemann L; Jacques Y
J Diabetes Sci Technol; 2009 May; 3(3):568-84. PubMed ID: 20144297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
